tradingkey.logo
tradingkey.logo
Search

Senti Biosciences Inc

SNTI
Add to Watchlist
0.341USD
-0.020-5.52%
Close 07-31 16:00ETQuotes delayed by 15 min
10.60MMarket Cap
LossP/E TTM

SNTI Financials

See Senti Biosciences Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Senti Biosciences Inc Earnings Date

Latest Release
May 14, 2026
EPS / Forecast
--/-0.36
Revenue / Forecast
--/0.00
Period
FY2025 Earnings
Revenue(YoY)
22.00K
--
EPS(YoY)
-2.73
76.21%
Analyst Rating
BUY
2026/07/31
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
90.33%-0.14
-303.21%-0.53
89.04%-0.69
97.69%-0.56
46.81%-1.41
96.88%-0.13
-87.95%-6.31
-480.20%-24.50
37.63%-2.65
-4.32%-4.19
---3.36
---4.22
---4.25
---4.02
---9.17
----
----
----
----
----
Revenue
--16.00K
--22.00K
----
----
----
--0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-80.86%338.00K
-31.00%937.00K
16.49%1.29M
-92.56%59.00K
60.11%1.77M
71.25%1.36M
1433.33%1.10M
39550.00%793.00K
--1.10M
--793.00K
Net Profit
70.09%-4.22M
-2271.64%-14.47M
37.21%-18.13M
-31.51%-14.73M
-16.52%-14.11M
96.74%-610.00K
-93.43%-28.87M
40.08%-11.20M
35.31%-12.11M
-2.78%-18.72M
10.32%-14.92M
-61.85%-18.70M
-58.55%-18.72M
-67.00%-18.21M
-45.89%-16.64M
3.79%-11.55M
43.78%-11.81M
-913.38%-10.90M
---11.41M
---12.01M
Net Margin
---26381.25%
---65759.09%
----
----
----
----
----
----
----
----
---10832.84%
---1520.81%
---1077.14%
---25403.39%
---820.37%
----
----
----
----
----
Gross Margin
--100.00%
--100.00%
----
----
----
----
----
----
----
----
--100.00%
--100.00%
--100.00%
--100.00%
--100.00%
----
----
----
----
----
Debt to assets ratio
----
----
----
----
----
29.67%0.11%
94.32%0.18%
15.91%0.12%
-5.97%0.10%
--0.08%
--0.09%
--0.10%
--0.10%
----
----
----
----
----
----
----
Revenue
--16.00K
--22.00K
----
----
----
--0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-80.86%338.00K
-31.00%937.00K
16.49%1.29M
-92.56%59.00K
60.11%1.77M
71.25%1.36M
1433.33%1.10M
39550.00%793.00K
--1.10M
--793.00K
Operating profit
29.88%-11.50M
15.98%-13.58M
-13.73%-16.95M
-25.77%-16.80M
-0.59%-16.40M
12.26%-16.17M
18.05%-14.90M
12.06%-13.36M
-8.93%-16.30M
-9.72%-18.43M
-23.30%-18.18M
30.24%-15.19M
-27.27%-14.96M
-54.29%-16.79M
-29.11%-14.75M
-142.01%-21.77M
-28.62%-11.76M
-66.23%-10.88M
---11.42M
---9.00M
Net Profit
70.09%-4.22M
-2271.64%-14.47M
37.21%-18.13M
-31.51%-14.73M
-16.52%-14.11M
96.74%-610.00K
-93.43%-28.87M
40.08%-11.20M
35.31%-12.11M
-2.78%-18.72M
10.32%-14.92M
-61.85%-18.70M
-58.55%-18.72M
-67.00%-18.21M
-45.89%-16.64M
3.79%-11.55M
43.78%-11.81M
-913.38%-10.90M
---11.41M
---12.01M
Current assets
-67.29%14.79M
-60.53%23.27M
4.45%18.16M
-26.65%32.52M
-18.78%45.21M
-17.19%58.96M
-78.00%17.38M
-30.17%44.34M
-30.86%55.67M
-30.59%71.20M
-34.03%79.01M
-55.88%63.49M
80.45%80.51M
70.42%102.58M
56.52%119.76M
--143.92M
--44.62M
--60.19M
--76.52M
----
Total current liabilities
33.02%14.27M
6.30%13.97M
32.69%12.03M
10.13%9.99M
11.62%10.73M
3.74%13.15M
-10.38%9.06M
-13.03%9.07M
-25.31%9.61M
-29.81%12.67M
-36.14%10.11M
-41.42%10.43M
-29.07%12.87M
24.14%18.05M
31.30%15.84M
--17.80M
--18.14M
--14.54M
--12.06M
----
Total assets
-53.80%38.24M
-47.65%51.22M
-8.72%52.69M
-21.14%68.54M
-18.99%82.78M
-18.11%97.84M
-56.19%57.72M
-39.49%86.91M
-36.70%102.19M
-33.91%119.48M
-30.44%131.77M
-29.02%143.63M
74.88%161.43M
86.96%180.79M
80.97%189.44M
--202.36M
--92.31M
--96.70M
--104.68M
----
Total liabilities
-20.58%35.68M
-3.08%45.63M
6.80%44.56M
2.63%43.89M
-2.54%44.92M
-10.43%47.09M
-14.55%41.73M
-7.46%42.77M
-6.10%46.09M
-1.79%52.57M
-0.55%48.83M
-3.91%46.21M
16.10%49.09M
47.36%53.53M
43.49%49.10M
--48.10M
--42.28M
--36.33M
--34.22M
----
Total equity
-93.22%2.56M
-88.99%5.59M
-49.22%8.12M
-44.16%24.65M
-32.51%37.86M
-24.15%50.76M
-80.72%15.99M
-54.68%44.15M
-50.07%56.09M
-47.42%66.91M
-40.90%82.94M
-36.85%97.42M
124.56%112.34M
110.78%127.26M
99.17%140.34M
--154.27M
--50.03M
--60.38M
--70.46M
----
Net operating income
46.75%-7.48M
49.09%-6.88M
-20.09%-9.45M
-56.66%-13.07M
-20.27%-14.05M
-91.90%-13.50M
48.85%-7.87M
38.98%-8.35M
28.35%-11.68M
21.86%-7.04M
-51.73%-15.38M
-140.12%-13.68M
-62.08%-16.30M
24.77%-9.01M
-15.12%-10.14M
-3.66%-5.70M
-20.25%-10.06M
-72.29%-11.97M
---8.80M
---5.49M
Net investment
--114.00K
100.00%0.00
-100.00%0.00
---184.00K
100.00%0.00
-110.89%-11.00K
-99.72%60.00K
-100.00%0.00
99.84%-15.00K
100.21%101.00K
248.88%21.14M
262.80%18.33M
-28.69%-9.50M
-1132.57%-49.12M
-1423.71%-14.20M
-2580.95%-11.26M
-3482.52%-7.38M
-384.79%-3.98M
---932.00K
---420.00K
Net financing
71.50%-118.00K
-78.48%11.04M
-94.92%124.00K
--1.01M
---414.00K
9124.82%51.29M
10708.70%2.44M
-100.00%0.00
100.00%0.00
-36.53%556.00K
95.26%-23.00K
-99.76%281.00K
92.31%-35.00K
3708.70%876.00K
-199.59%-485.00K
84.28%118.61M
-112.79%-455.00K
-99.92%23.00K
--487.00K
--64.37M

FAQs

What is the total revenue of Senti Biosciences Inc?

According to Senti Biosciences Inc's FY2025 earnings report, its total revenue reached 22.00K, with a year-on-year change of 22.00K.

What are the current assets of Senti Biosciences Inc?

According to Senti Biosciences Inc's FY2025 earnings report, its current assets were 23.27M, with a year-on-year change of -60.53.

What are the total assets of Senti Biosciences Inc?

According to Senti Biosciences Inc's FY2025 earnings report, its total assets of Senti Biosciences Inc were 51.22M, with a year-on-year change of -47.65.

What are the total liabilities of Senti Biosciences Inc?

According to Senti Biosciences Inc's FY2025 earnings report, its total liabilities of Senti Biosciences Inc were 45.63M, with a year-on-year change of -3.08.

What is the total equity of Senti Biosciences Inc?

According to Senti Biosciences Inc's FY2025 earnings report, its total equity of Senti Biosciences Inc was 5.59M, with a year-on-year change of -88.99.

What is the net operating income of Senti Biosciences Inc?

According to Senti Biosciences Inc's FY2025 earnings report, its net operating income of Senti Biosciences Inc was -63.73M, with a year-on-year change of -4.94.

What is the net investment of Senti Biosciences Inc?

According to Senti Biosciences Inc's FY2025 earnings report, its net investment of Senti Biosciences Inc was -184.00K, with a year-on-year change of -641.18.

What is the net financing of Senti Biosciences Inc?

According to Senti Biosciences Inc's FY2025 earnings report, its net financing of Senti Biosciences Inc was 11.76M, with a year-on-year change of -78.11.

What is the Earnings Per Share (EPS) of Senti Biosciences Inc?

According to Senti Biosciences Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -2.73, with a year-on-year change of 76.21.

What is the net income of Senti Biosciences Inc?

According to Senti Biosciences Inc's FY2025 earnings report, its net income was -61.44M, with a year-on-year change of -16.38.

What is the Return on Equity (ROE) of Senti Biosciences Inc?

According to Senti Biosciences Inc's FY2025 earnings report, its Return on Equity (ROE) was -393.35, with a year-on-year change of -244.85.

What is the Return on Assets (ROA) of Senti Biosciences Inc?

According to Senti Biosciences Inc's FY2025 earnings report, its Return on Assets (ROA) was -82.43, with a year-on-year change of -69.68.

What is the operating profit of Senti Biosciences Inc?

According to Senti Biosciences Inc's FY2025 earnings report, its operating profit was -63.73M, with a year-on-year change of -4.94.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.